146 related articles for article (PubMed ID: 25140852)
1. Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.
Blackwell CW
Nurse Pract; 2014 Sep; 39(9):50-3. PubMed ID: 25140852
[TBL] [Abstract][Full Text] [Related]
2. Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
Coutinho B; Prasad R
Am Fam Physician; 2013 Oct; 88(8):535-40. PubMed ID: 24364575
[No Abstract] [Full Text] [Related]
3. Transmission. Company halts Truvada PrEP for women study.
AIDS Policy Law; 2011 Jun; 26(7):1. PubMed ID: 21735622
[No Abstract] [Full Text] [Related]
4. HIV pre-exposure prophylaxis.
Morin SF; Yamey G; Rutherford GW
BMJ; 2012 Aug; 345():e5412. PubMed ID: 22890030
[No Abstract] [Full Text] [Related]
5. Preexposure prophylaxis for HIV infection.
Steinbrook R
JAMA; 2012 Sep; 308(9):865-6. PubMed ID: 22820712
[No Abstract] [Full Text] [Related]
6. FDA approves first drug to prevent HIV infection.
Roehr B
BMJ; 2012 Jul; 345():e4879. PubMed ID: 22807165
[No Abstract] [Full Text] [Related]
7. [PrEP approved in the USA: facts and discussion - permanent chemoprophylaxis for healthy people].
Marcus U
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():42-4. PubMed ID: 23961656
[No Abstract] [Full Text] [Related]
8. AIDS research. FDA panel recommends anti-HIV drug for prevention.
Cohen J
Science; 2012 May; 336(6083):792. PubMed ID: 22605725
[No Abstract] [Full Text] [Related]
9. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada.
Karris MY; Beekmann SE; Mehta SR; Anderson CM; Polgreen PM
Clin Infect Dis; 2014 Mar; 58(5):704-12. PubMed ID: 24319083
[TBL] [Abstract][Full Text] [Related]
10. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
11. Emtricitabine + tenofovir to prevent HIV transmission. More evaluation needed.
Prescrire Int; 2013 Jul; 22(140):178-81. PubMed ID: 23951592
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?
De Clercq E
Med Res Rev; 2012 Jul; 32(4):765-85. PubMed ID: 22581627
[TBL] [Abstract][Full Text] [Related]
13. Uptake of PrEP for HIV slow among MSM.
Kirby T; Thornber-Dunwell M
Lancet; 2014 Feb; 383(9915):399-400. PubMed ID: 24494225
[No Abstract] [Full Text] [Related]
14. Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs.
Sachdev DD; Stojanovski K; Liu AY; Buchbinder SP; Macalino GE
Clin Infect Dis; 2014 Jun; 58(12):1786-7. PubMed ID: 24729556
[No Abstract] [Full Text] [Related]
15. Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand.
Sineath RC; Finneran C; Sullivan P; Sanchez T; Smith DK; Griensven Fv; Wimonsate W; Stephenson R
J Int Assoc Provid AIDS Care; 2013; 12(4):227-31. PubMed ID: 23708677
[TBL] [Abstract][Full Text] [Related]
16. Preexposure prophylaxis for the prevention of HIV transmission to women.
Aaron E; Cohan D
AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
[TBL] [Abstract][Full Text] [Related]
17. Truvada for HIV prophylaxis in heterosexual patients.
DeDea L
JAAPA; 2012 Oct; 25(10):14. PubMed ID: 23115862
[No Abstract] [Full Text] [Related]
18. [HIV preexposure prophylaxis].
Olczak A; Grabczewska E
Przegl Epidemiol; 2012; 66(1):79-82. PubMed ID: 22708303
[TBL] [Abstract][Full Text] [Related]
19. The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK.
McCormack S; Fidler S; Fisher M; ;
Int J STD AIDS; 2012 Jan; 23(1):1-4. PubMed ID: 22362679
[No Abstract] [Full Text] [Related]
20. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):586-9. PubMed ID: 22874836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
